Cancer Stem Cells and Personalized Cancer Nanomedicine
Petra Gener(CIBBIM-Nanomedicine), Simó Schwartz(CIBBIM-Nanomedicine), Joan Sayós(Beth Israel Deaconess Medical Center), Ibane Abasolo(Universitat Autònoma de Barcelona), Diego Arango(Universitat Autònoma de Barcelona), Mafalda Videira(University of Lisbon), Yolanda Fernández(CIBBIM-Nanomedicine), Diana Rafael(University of Lisbon)
Cited by 31
Related Papers
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
|British Journal of Cancer|2004|275
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Immune system targeting by biodegradable nanoparticles for cancer vaccines
|Journal of Controlled Release|2013|229
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
|Journal of drug targeting|2002|210